Clinical Trial Update: C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for C1-Esteraseremmer-N in hereditary and acquired angioedema; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Angioedema
• Hereditary Angioedema

Drugs mentioned

• C1-Esteraseremmer-N

Snippet

Sponsor: Prothya Biosolutions | Conditions: Angioedema | Phase 3 | Status: COMPLETED